Dr. Setu Kasera joined ATAI Life Sciences in 2020. Previously, Dr. Kasera was a Biopharma Strategy Consultant at Catenion where she evaluated drug assets to advise VC clients.
Prior to that, she was Director of Operations at Chalante, an early-stage company focused on drug discovery in animal health and Senior Technical & Business Analyst at Acidophil, a biotech focused in chemicals and drug discovery. During her postdoctoral training at University of Cambridge, UK, she led pre-commercialisation activities for a co-invented sensor technology in medical diagnostics and received executive entrepreneurial training at Judge Business School.
Dr. Kasera holds a BSc in Biological Chemistry from Aston University, UK and, an MPhil and a PhD in Chemistry from University of Cambridge, UK.